Table 1.
Patient Baseline Characteristics
| Variable | Placebo (N=1167) | 30 mg day (N=1154) | 60 mg day (N=1162) | P -value |
|---|---|---|---|---|
| Age (years) | 62.1 ± 11.9 | 62.1 ± 12.4 | 62.5 ± 12.0 | 0.65 |
| Sex, No. (%) | 0.09 | |||
| Male | 887 (76%) | 867 (75%) | 916 (79%) | |
| Female | 280 (24%) | 287 (25%) | 246 (21%) | |
| Race, No. (%) | 0.42 | |||
| Caucasian | 989 (85%) | 989 (86%) | 985 (85%) | |
| Black | 152 (13%) | 137 (12%) | 149 (13%) | |
| Hispanic | 18 (2%) | 15 (1%) | 18 (2%) | |
| Asian | 4 (0%) | 3 (0%) | 7 (1%) | |
| Other | 4 (0%) | 10 (1%) | 3 (0%) |